Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Clinical trials have shown that adults taking tirzepatide (brand-name) achieve significantly greater weight loss with an average reduction of about 20% of their body weight, compared to those taking semaglutide
For example, the benefits for overweight/obese individuals were highlighted in the SURMOUNT-1 trial, which involved overweight/obese individuals with an average weight of 104.8 kg and a BMI of 38.0, indicating that tirzepatide could be a new option for weight loss in this specific population
Trn th trng c rt nhiu sn phm khc nhau, nhng khng phi loi no cng an ton v mang li hiu qu nh mong mun
This gradual escalation is based on clinical trials showing that slower progression improves tolerability and allows identification of your optimal dose
Being informed helps you make safe choices
Oliak or PA Mollet to get started today
.svg)
